News
10-19-2010, 04:15 AM
Scientists at the Barbara Ann Karmanos Cancer Institute in Detroit have received a nearly $3 million, five-year research project (RO1) grant from the National Institutes of Health to study a potentially ground-breaking immunotherapy treatment for women with one of the deadliest forms of breast cancer triple-negative breast cancer. The research is exclusive to the Karmanos Cancer Institute...
More... (http://mnt.to/f/3Lpt)
More... (http://mnt.to/f/3Lpt)